Navigation Links
Biologists discover why 10% of Europeans are safe from HIV

Biologists at the University of Liverpool have discovered how the plagues of the Middle Ages have made around 10% of Europeans resistant to HIV. Scientists have known for some time that these individuals carry a genetic mutation (known as CCR5-delta32) that prevents the virus from entering the cells of the immune system but have been unable to account for the high levels of the gene in Scandinavia and relatively low levels in areas bordering the Mediterranean.

They have also been puzzled by the fact that HIV emerged only recently and could not have played a role in raising the frequency of the mutation to the high levels found in some Europeans today.

Professor Christopher Duncan and Dr Susan Scott from the University's School of Biological Sciences, whose research is published in the March edition of Journal of Medical Genetics, attribute the frequency of the CCR5-delta32 mutation to its protection from another deadly viral disease, acting over a sustained period in bygone historic times.

Some scientists have suggested this disease could have been smallpox or even bubonic plague but bubonic plague is a bacterial disease rather than a virus and is not blocked by the CCR5-delta32 mutation.

Professor Duncan commented: "The fact that the CCR5-delta32 mutation is restricted to Europe suggests that the plagues of the Middle Ages played a big part in raising the frequency of the mutation. These plagues were also confined to Europe, persisted for more than 300 years and had a 100% case mortality."

Around 1900, historians spread the idea that the plagues of Europe were not a directly infectious disease but were outbreaks of bubonic plague, overturning an accepted belief that had stood for 550 years. Professor Duncan and Dr Scott illustrated in their book, Return of the Black Death (2004, Wiley), that this idea was incorrect and the plagues of Europe (1347-1660) were in fact a continuing series of epidemics of a lethal, viral, haemorrha gic fever that used the CCR5 as an entry port into the immune system. Using computer modeling, they demonstrated how this disease provided the selection pressure that forced up the frequency of the mutation from 1 in 20,000 at the time of the Black Death to values today of 1 in 10.

Lethal, viral haemorrhagic fevers were recorded in the Nile valley from 1500 BC and were followed by the plagues of Mesopotamia (700-450BC), the plague of Athens (430BC), the plague of Justinian (AD541-700) and the plagues of the early Islamic empire (AD627-744). These continuing epidemics slowly raised the frequency from the original single mutation to about 1 in 20,000 in the 14th century simply by conferring protection from an otherwise certain death.

Professor Duncan added: "Haemorrhagic plague did not disappear after the Great Plague of London in 1665-66 but continued in Sweden, Copenhagen, Russia, Poland and Hungary until 1800. This maintenance of haemorrhagic plague provided continuing selection pressure on the CCR5-delta32 mutation and explains why it occurs today at its highest frequency in Scandinavia and Russia."


'"/>

Source:Universty of Liverpool


Related biology news :

1. Biologists determine genetic blueprint of social amoeba
2. Biologists Crack Genetic Code for Specialized Spider Silk
3. Biologists discover new pathway into plant cells
4. Biologists visualize protein interaction that may initiate viral infection
5. Biologists develop genome-wide map of miRNA-mRNA interactions
6. How healthy is that marsh? Biologists count parasites
7. Biologists find regions of rice domestication
8. Biologists probe the machinery of cellular protein factories
9. Biologists call for better choice of model organisms in evo-devo
10. Biologists produce global map of plant biodiversity
11. Biologists prove critical step in membrane fusion
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2018)... ... 21, 2018 , ... VTE can present as deep vein ... significant morbidity and mortality. VTE affects between 300-600,000 Americans annually, with approximately 100,000 ... the leading cause of preventable hospital death and maternal mortality. When used with ...
(Date:9/12/2018)... ... September 10, 2018 , ... IONpathTM, a venture-backed commercial-stage ... Multiplexed Ion Beam Imaging (MIBITM) technology was accepted by the journal Cell and ... shared during a webinar presented by Dr. Mike Angelo on October 2nd, 2018. ...
(Date:9/12/2018)... , ... September 12, 2018 , ... ... spine fusion solutions announced today it has received 510(k) clearance from the U.S. ... complementing its TowerLOX® MIS Pedicle Screw System. , TowerLOX-EXT MIS Extended Tab Pedicle ...
Breaking Biology News(10 mins):
(Date:8/31/2018)... (PRWEB) , ... August 29, 2018 , ... ... Professorships at both the University of Southampton and the Institute of Industrial Science, ... intelligence at sea can dramatically accelerate the exploration and study of hard to ...
(Date:8/29/2018)... ... 28, 2018 , ... CEO and founder of VetStem Biopharma, ... on an allogeneic (donor derived) stem cell product for osteoarthritis in canines at ... September. He is also the organizer of Breakout Session 4: Practitioner Primer on ...
(Date:8/23/2018)... Nev. (PRWEB) , ... August 22, 2018 , ... ... TrialKit ™ for Android on September 1st, making it the first fully-featured app ... iOS and Android devices. Combined, iOS and Android constitute 99 percent of the ...
(Date:8/17/2018)... ... August 16, 2018 , ... KCAS ... to announce the expansion of their team. Dr. Dawn Dufield, Ph.D., joins KCAS ... innovative large molecule LC-MS/MS group that will specialize in developing quantitative LC-MS/MS assays ...
Breaking Biology Technology: